Overmorgen zullen resultaten bekend worden gemaakt van een klinische studie (fase II) bij uitgezaaid #oogmelanoom : entinostat (HDAC-remmer) + pembrolizumab https://t.co/l0NpVHMNJH #LBA = Late Breaking Abstract 👇#ESMO19 https://t.co/C01lHO6Dsh
1,223 followers
113 followers
RT @ingentium_mel: Concomitant use of pembrolizumab and entinostat in adult patients with metastatic #UvealMelanoma #melanoma (PEMDAC study…
196 followers
Concomitant use of pembrolizumab and entinostat in adult patients with metastatic #UvealMelanoma #melanoma (PEMDAC study): protocol for a multicenter phase II open label study. https://t.co/DyLqVkX5zh